The global pharmaceutical industry came together at CPHI Japan 2026, one of Asia’s leading pharmaceutical networking and business platforms, attracting over 35,000 attendees and 700+ exhibiting companies from more than 70 countries.
As part of its continued commitment toward strengthening international pharmaceutical partnerships, CHP proudly sponsored an exclusive Cocktail Networking Evening during the exhibition. The event served as a strategic platform for industry leaders, innovators, manufacturers, and decision-makers from across the global healthcare ecosystem to connect in an informal yet highly impactful setting.
The networking evening successfully brought together distinguished delegates from India and Japan, further reinforcing the growing collaboration between the two nations in pharmaceuticals, healthcare innovation, contract manufacturing, APIs, biotechnology, and advanced healthcare solutions.
Some of the distinguished personalities recognized during the ceremony included:
● Dr. Lekh Juneja: Chairman & CEO, Kameda Seika Ltd (Japan)
● Iwao Fusejima: President & CEO, Freund Corporation (Japan)
● Swathi Reddy Gunupati: Executive Director, Matrix Pharmacorp (India)
● Nupur Tewari: Founder & CEO, Connect India Japan (Japan)
● Makota Matsukawa: President, Sfida Healthcare (Japan)
● Dinesh Dendukuri: Director, Katsuyama Pharmaceuticals (Japan)
● Wataru Ohama: President & CEO, Higuchi Inc (Japan)
● Mr. Taketo Okutani : Managing Executive Officer & CIO OJI HOLDINGS CORP
● Girish Chovatia: Chairman & MD, Ami Lifesciences (India)
● Christopher Eve: Senior Vice President, Asia, Informa Markets
● Nobuaki Nito: General Manager, Informa Japan
The event reflected CHP’s dedication toward building stronger global healthcare partnerships and creating opportunities for collaboration between Indian and Japanese pharmaceutical organizations.
The successful participation and sponsorship at CPHI Japan 2026 further reaffirmed CHP’s growing presence within the global pharmaceutical ecosystem and its commitment toward driving future industry collaborations.